Who benefits most from postbiotics?

Who benefits most from postbiotics?

The people who benefit most are those who cannot safely take live probiotics—infants, the elderly, and people with compromised immune systems or underlying diseases. Postbiotics are dead microbes or their components, so they cannot cause infections or adverse reactions in vulnerable populations [11]. A technical review by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) examined 12 randomized controlled trials and found that postbiotic-supplemented infant formulas were well-tolerated and supported normal growth in healthy infants, with no difference in safety or side effects compared to standard formula [1]. This makes postbiotics a safe option for newborns who cannot be breastfed.

People with chronic kidney disease (CKD) also appear to benefit significantly. In a mouse model of cisplatin-induced CKD, treatment with postbiotics from Limosilactobacillus fermentum reduced blood urea nitrogen (BUN) and creatinine levels (both p < 0.0001), lowered oxidative stress markers, and improved kidney tissue health—in some tests, the postbiotic worked better than the live probiotic [2]. This suggests postbiotics could be a promising supplement for CKD patients, who often have compromised gut health.

For the general population, postbiotics offer a stable, shelf-stable alternative to probiotics for supporting gut health, immunity, and reducing inflammation. A comprehensive review noted that postbiotics have antioxidant, antimicrobial, anti-inflammatory, and immunomodulatory effects, and can strengthen the gut barrier [3][8]. They are also easier to manufacture and store than live probiotics, making them more practical for functional foods and supplements [4][7].

What the evidence shows—and what it doesn't

The strongest evidence supports postbiotics for gut health, immune modulation, and safety in vulnerable groups. Multiple reviews agree that postbiotics can inhibit pathogens, strengthen the gut lining, and regulate immune responses [6][8][12]. For example, a 2024 review highlighted that postbiotics preserve microbiota balance and control immune function through bioactive metabolites [12]. Another review found that postbiotics from lactic acid bacteria show strain-specific antibacterial and antifungal activity, and some fractions even inhibited the growth of a leukemia cell line in lab tests [10]. However, these are lab results, not human trials.

Where the evidence is weaker or absent: claims about cancer treatment, allergy prevention, and cardiovascular benefits are still preliminary. A review on colorectal cancer noted that while postbiotics show promise in lab studies, comprehensive data on their molecular identity, mechanisms, and optimal delivery are lacking [9]. Similarly, the ESPGHAN review found no difference between postbiotic-supplemented and standard infant formulas for allergy or infection outcomes [1]. The authors stressed that studies are heterogeneous—different postbiotics, doses, and durations—making it hard to draw firm conclusions. So while postbiotics are safe and well-tolerated, their specific disease-fighting benefits need more research.

Another important caveat: safety data for postbiotics is still limited. A 2024 review noted that because in vivo research is scarce, the safety of postbiotics is not fully confirmed, especially for long-term use [11]. The same review pointed out that while postbiotics are generally considered safer than live probiotics, more human studies are needed to rule out rare adverse effects.

How do postbiotics compare to probiotics?

Postbiotics have clear advantages over probiotics in stability, safety, and ease of use. Live probiotics must survive processing, storage, and the harsh conditions of the stomach to work; postbiotics bypass this because they are already dead or are just the active components [7]. This makes them ideal for food products and supplements that need a long shelf life [4]. A 2022 review noted that postbiotics can mimic the health benefits of probiotics—anti-inflammatory, immunomodulatory, antimicrobial—without the risk of live bacteria causing infections [7].

However, postbiotics are not necessarily better than probiotics in every way. In the kidney disease study, the postbiotic outperformed the live probiotic on some markers (like reducing oxidative stress), but not all [2]. In the infant formula trials, postbiotics were equivalent to standard formula—they didn't show extra benefits over live probiotics for growth or allergy prevention [1]. So while postbiotics are a safe and stable alternative, they may not always be more effective. The choice depends on the specific health goal and the population.

A key point from the International Scientific Association for Probiotics and Prebiotics (ISAPP) definition: postbiotics must contain inactivated microbes or their components, not just metabolic byproducts [5]. This means not all fermented foods or probiotic metabolites qualify as postbiotics—only those that include the dead cells or cell fragments. This distinction matters for consumers reading labels.

About These Sources

This answer is built on 12 peer-reviewed studies — published from 2022 to 2026, 6 from 2024 or later, 7 in Q1 journals, collectively cited 794 times — selected as the most relevant from 15 studies that passed quality screening, drawn from 55 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions